HealthStream Beheer

Beheer criteriumcontroles 4/4

De CEO HealthStream is Bobby Frist, benoemd in Jan1990, heeft een ambtstermijn van 34.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 727.11K, bestaande uit 52.3% salaris en 47.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 17.92% van de aandelen van het bedrijf, ter waarde € 170.59M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.3 jaar en 23.8 jaar.

Belangrijke informatie

Bobby Frist

Algemeen directeur

US$727.1k

Totale compensatie

Percentage CEO-salaris	52.3%
Dienstverband CEO	34.8yrs
Eigendom CEO	17.9%
Management gemiddelde ambtstermijn	7.3yrs
Gemiddelde ambtstermijn bestuur	23.8yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Bobby Frist's beloning veranderd ten opzichte van HealthStream's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	US$20m
Jun 30 2024	n/a	n/a	US$18m
Mar 31 2024	n/a	n/a	US$18m
Dec 31 2023	US$727k	US$380k	US$15m
Sep 30 2023	n/a	n/a	US$13m
Jun 30 2023	n/a	n/a	US$13m
Mar 31 2023	n/a	n/a	US$12m
Dec 31 2022	US$750k	US$375k	US$12m
Sep 30 2022	n/a	n/a	US$9m
Jun 30 2022	n/a	n/a	US$7m
Mar 31 2022	n/a	n/a	US$6m
Dec 31 2021	US$642k	US$358k	US$6m
Sep 30 2021	n/a	n/a	US$7m
Jun 30 2021	n/a	n/a	US$8m
Mar 31 2021	n/a	n/a	US$9m
Dec 31 2020	US$577k	US$345k	US$14m
Sep 30 2020	n/a	n/a	US$17m
Jun 30 2020	n/a	n/a	US$18m
Mar 31 2020	n/a	n/a	US$17m
Dec 31 2019	US$617k	US$342k	US$14m
Sep 30 2019	n/a	n/a	US$14m
Jun 30 2019	n/a	n/a	US$13m
Mar 31 2019	n/a	n/a	US$14m
Dec 31 2018	US$602k	US$331k	US$13m
Sep 30 2018	n/a	n/a	US$13m
Jun 30 2018	n/a	n/a	US$12m
Mar 31 2018	n/a	n/a	US$11m
Dec 31 2017	US$533k	US$319k	US$9m

Compensatie versus markt: De totale vergoeding ($USD 727.11K ) Bobby } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 1.42M ).

Compensatie versus inkomsten: De vergoeding van Bobby is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Bobby Frist (57 yo)

34.8yrs

Tenure

US$727,109

Compensatie

Mr. Robert A. Frist, Jr., also known as Bobby, is a Co-founder of Healthstream, Inc. and has been its Chief Executive Officer and Director since 1990. He serves as Member of Advisory Board at PsychHub, LLC...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Robert Frist	Co-Founder	34.8yrs	US$727.11k	17.92% € 170.6m
Scott Roberts	CFO & Senior VP	5.8yrs	US$685.90k	0.076% € 725.2k
Michael Sousa	Executive Vice President of Enterprise Applications	no data	US$955.83k	0.18% € 1.7m
Michael Collier	Executive Vice President of Corporate Strategy & Development	no data	US$834.25k	0.13% € 1.3m
Trisha Coady	Senior Vice President of Workforce Development Solutions	6yrs	US$706.01k	0.077% € 737.5k
Jeffrey Cunningham	Senior VP & CTO	7.3yrs	US$482.35k	0.085% € 813.3k
Mollie Condra	Vice President of Investor Relations & Communications	no data	geen gegevens	geen gegevens
Sneha Oakley	VP, Compliance Officer & General Counsel	no data	geen gegevens	geen gegevens
Scott Fenstermacher	Senior Vice President of Sales	7.3yrs	geen gegevens	0.041% € 390.5k
Kevin O'Hara	Senior Vice President of Platform Solutions	no data	US$695.90k	0.034% € 320.2k
Michael McQuigg	Senior Vice President of Digital & Network Development	5.8yrs	geen gegevens	0.071% € 674.9k
Arthur Newman	Senior Executive Advisor	no data	US$429.29k	geen gegevens

7.3yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van HL5 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Robert Frist	Co-Founder	34.8yrs	US$727.11k	17.92% € 170.6m
Thompson Dent	Lead Independent Director	29.8yrs	US$118.01k	0.44% € 4.2m
Terry Rappuhn	Independent Director	2.8yrs	US$117.50k	0.012% € 118.3k
Jeffrey McLaren	Independent Director	34.8yrs	US$110.51k	0.064% € 604.6k
William Stead	Independent Director	26.8yrs	US$113.01k	0.14% € 1.3m
Linda Rebrovick	Independent Director	23.8yrs	US$111.60k	0.18% € 1.7m
Frank Gordon	Independent Director	22.8yrs	US$112.51k	0.75% € 7.1m
Deborah Tate	Independent Director	14.8yrs	US$110.51k	0.070% € 670.6k
Alex Jahangir	Independent Director	1.4yrs	US$102.65k	0.0037% € 35.2k

23.8yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van HL5 zijn ervaren en ervaren (gemiddelde ambtstermijn van 23.8 jaar).

HealthStream Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

HealthStream, Inc., Annual General Meeting, May 30, 2024

Insider recently sold €170k worth of stock

HealthStream Announces the Addition of Dr. Alex Jahangir to the Board of Directors

HealthStream, Inc. Approves the Retirement of Michael D. Shmerling as Director

President & COO recently sold €343k worth of stock

Independent Director recently sold €81k worth of stock

Recent updates

HealthStream, Inc. (NasdaqGS:HSTM) acquired Substantially All Assets of Total Clinical Placement System and The Clinical Hub, Inc. from Cyber Healthcare Solutions, LLC for $2.25 million.

HealthStream, Inc. Revises Earnings Guidance for the Full Year 2024

HealthStream, Inc. to Report Q3, 2024 Results on Oct 21, 2024

Second quarter 2024 earnings released: EPS: US$0.14 (vs US$0.14 in 2Q 2023)

Healthstream, Inc. Approves Quarterly Cash Dividend, Payable on August 16, 2024

HealthStream, Inc. to Report Q2, 2024 Results on Jul 22, 2024

Now 21% undervalued

First quarter 2024 earnings released: EPS: US$0.17 (vs US$0.086 in 1Q 2023)

HealthStream, Inc. Reaffirms Earnings Guidance for 2024

HealthStream, Inc. to Report Q1, 2024 Results on Apr 22, 2024

HealthStream, Inc., Annual General Meeting, May 30, 2024

Upcoming dividend of US$0.028 per share

Insider recently sold €170k worth of stock

Full year 2023 earnings released: EPS: US$0.50 (vs US$0.40 in FY 2022)

HealthStream, Inc. Announces Increases Quarterly Dividend, Payable on March 22, 2024

HealthStream, Inc. to Report Q4, 2023 Results on Feb 19, 2024

Now 23% undervalued

Upcoming dividend of US$0.025 per share at 0.4% yield

Now 24% undervalued

HealthStream, Inc. Updates Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.13 (vs US$0.12 in 3Q 2022)

HealthStream, Inc. to Report Q3, 2023 Results on Oct 23, 2023

HealthStream, Inc. (NasdaqGS:HSTM) announces an Equity Buyback for $10 million worth of its shares.

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.10 in 2Q 2022)

Healthstream, Inc. Provides Revenue Guidance for the Year 2023

HealthStream Announces the Addition of Dr. Alex Jahangir to the Board of Directors

Upcoming dividend of US$0.025 per share at 0.4% yield

HealthStream, Inc. Approves the Retirement of Michael D. Shmerling as Director

President & COO recently sold €343k worth of stock

First quarter 2023 earnings released: EPS: US$0.086 (vs US$0.093 in 1Q 2022)

Upcoming dividend of US$0.025 per share at 0.4% yield

Independent Director recently sold €81k worth of stock

Full year 2022 earnings released: EPS: US$0.40 (vs US$0.18 in FY 2021)

HealthStream, Inc. to Report Q4, 2022 Results on Feb 20, 2023

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all of the assets from Electronic Education Documentation System, LLC for $7 million.

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all of the assets from Electronic Education Documentation System, LLC for $7 million.

Insufficient new directors

Third quarter 2022 earnings released: EPS: US$0.12 (vs US$0.048 in 3Q 2021)

HealthStream, Inc. to Report Q3, 2022 Results on Oct 24, 2022

Independent Director recently sold €118k worth of stock

Healthstream, Inc. Provides Earnings Guidance for the Year 2022

Second quarter 2022 earnings released: EPS: US$0.10 (vs US$0.077 in 2Q 2021)

HealthStream, Inc. to Report Q2, 2022 Results on Jul 25, 2022

HealthStream, Inc. (NasdaqGS:HSTM) acquired the remaining 80% stake in CloudCME, LLC for $8.1 million.

First quarter 2022 earnings released: EPS: US$0.093 (vs US$0.073 in 1Q 2021)

Insufficient new directors

HealthStream, Inc. Reiterates Earnings Guidance for the Fiscal Year 2022

HealthStream, Inc. to Report Q1, 2022 Results on Apr 25, 2022

HealthStream, Inc., Annual General Meeting, May 26, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

HealthStream, Inc. Provides Earnings Guidance for the Full Year 2022

HealthStream, Inc. to Report Q4, 2021 Results on Feb 21, 2022

HealthStream, Inc. (NasdaqGS:HSTM) acquired Substantially All Assets of Rievent Technologies for $4 million.

HealthStream, Inc. (NasdaqGS:HSTM) announces an Equity Buyback for $20 million worth of its shares.

Independent Director recently bought €88k worth of stock

Third quarter 2021 earnings released: EPS US$0.048 (vs US$0.082 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.077 (vs US$0.11 in 2Q 2020)

Chairman recently bought €186k worth of stock

First quarter 2021 earnings released: EPS US$0.073 (vs US$0.22 in 1Q 2020)

HealthStream, Inc.Provides Earnings Guidance for the Year 2021

Independent Director recently sold €78k worth of stock

Independent Director has left the company

C. Martin Harris, M.D. Notifies HealthStream, Inc. His Decision to Resign as Member of its Board of Directors

Full year 2020 earnings released: EPS US$0.44 (vs US$0.44 in FY 2019)

Revenue beats expectations

HealthStream, Inc. to Report Q4, 2020 Results on Feb 23, 2021

HealthStream, Inc.(NasdaqGS:HSTM) dropped from Russell 2000 Growth-Defensive Index

HealthStream, Inc. (NasdaqGS:HSTM) acquired ProcessDATA, Ltd. for approximately $2 million.

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all assets of myClinicalExchange LLC for $4.5 million.